AtG Therapeutics specializes in the development of therapeutic techniques for cancer resistance to improve the lives of cancer patients.
AtG Therapeutics has raised $214K in total funding. The most recent round was Debt Financing. The last funding was announced in June 2024.
AtG Therapeutics's investors include ICF Capital, Inveniam, WA4STEAM, Blue Goose Capital.
AtG Therapeutics is headquartered in Barcelona, Spain.
AtG Therapeutics specializes in the development of therapeutic techniques for cancer resistance to improve the lives of cancer patients.
AtG Therapeutics is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AtG Therapeutics — Funding & Investors." VCBacked, June 21, 2024, https://www.vcbacked.co/company/atg-therapeutics. Accessed October 2, 2026.
VCBacked. (2024). AtG Therapeutics — Funding & Investors. Retrieved October 2, 2026, from https://www.vcbacked.co/company/atg-therapeutics
{{cite web |title=AtG Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/atg-therapeutics |website=VCBacked |access-date=October 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated